Hainan Cancer Hospital

This early study is testing a new two-part cell therapy for people with advanced solid cancers that have not responded to standard treatments. It combines two types of modified immune cells—dendritic cells and CAR-T cells—to try to help the immune system find and kill cancer cell…

This early-phase study is testing a new two-part cell therapy for people with advanced pancreatic cancer that has stopped responding to standard treatments. It combines two types of specially prepared immune cells: one to help break down the tumor's defenses and another to seek o…